Phaedra Chrousos

Insider Reports History

Location
Washington, DC
Signature
/s/ Phaedra Chrousos
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phaedra Chrousos:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. Director Common Stock 123,350 $487,232 $3.95 05 Jun 2025 Direct

Insider Reports Filed by Phaedra Chrousos

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VNDA Vanda Pharmaceuticals Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 17:35
VNDA Vanda Pharmaceuticals Inc. 22 May 2024 2 $0 4 Director 24 May 2024, 16:43
VNDA Vanda Pharmaceuticals Inc. 08 Jun 2023 2 $0 4 Director 12 Jun 2023, 16:17
VNDA Vanda Pharmaceuticals Inc. 16 Jun 2022 2 $0 4 Director 21 Jun 2022, 16:53
VNDA Vanda Pharmaceuticals Inc. 14 Jun 2021 1 -$40,132 4 Director 15 Jun 2021, 16:42
VNDA Vanda Pharmaceuticals Inc. 10 Jun 2021 2 $0 4 Director 14 Jun 2021, 16:34